VMD Sciences

Name

VMD Sciences

Legal name

VMD Sciences

Website

https://vmdsciences.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceutical Access Services

NAICS

Veterinary Services (541940)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

akta.pro secondary industries

Online Veterinary Pharmacies & E-commerce Retailers (HLAMAIAF), Regulatory, Health Certificates & Export/Import Compliance (Large Animal/Equine) (HLAMABAL), Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns) (HLAMAIAG)

Keywords

• Veterinary managed access
• Veterinary medicine importation
• Drug shortage solutions
• Clinical study services
• Veterinary pharmaceutical services

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Managed Access Program Services: VMD Sciences guides pharmaceutical partners through the entire VMAP lifecycle, including protocol design, patient enrollment, data collection, and post-program regulatory submission support. Revenue generated from service fees for regulatory documentation, program management, and regulatory submission support.
2. Importation Services: Pricing includes international exchange rates and VMD Sciences' services covering regulatory documentation, product sourcing/ordering, and shipping and customs management. Tariffs and fees may apply and are determined by the carrier during or after transit, responsibility of the ordering Veterinarian/Pharmacist.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

VMD Sciences provides veterinary pharmaceutical access services by bridging the gap between treatments approved outside the United States and U.S. veterinarians facing drug shortages or unmet medical needs. The company operates Veterinary Managed Access Programs (VMAPs), Clinical Study Solutions, Drug Shortages Solutions, and a Global Veterinary Export Pharmacy that facilitates compliant importation of foreign-approved medications. Revenue is generated through service fees covering regulatory documentation, product sourcing, program management, and customs handling.

Product overview

VMD Sciences operates as a service-based veterinary medicine company offering a portfolio of access solutions rather than a traditional software product. The core offering consists of Veterinary Managed Access Programs (VMAPs) which bridge critical gaps in veterinary care by facilitating access to treatments approved in other countries. These MAPs are complemented by Clinical Study Solutions providing end-to-end research support for in-clinic animal studies, a Global Export Pharmacy (based in Lake Worth, Florida) enabling compliant access to FDA/USDA-approved medications for international veterinary practices, and Drug Shortages Solutions addressing supply constraints through importation pathways. The VMD Access online platform serves as the digital portal where licensed veterinarians and pharmacists can request treatments, browse eligible options, and manage importations. Together, these services form an integrated ecosystem for accelerating global veterinary medicine access.

Differentiator

Problem solved

Functional benefit

Brands

• VMD Access: Resource center for licensed Veterinarians and Pharmacists providing access to global treatments through importation programs.
• VMAPs (Veterinary Managed Access Programs)
• Global Veterinary Export Pharmacy

Products and services

• Veterinary Managed Access Programs (VMAPs) A program designed to bridge critical gaps in veterinary care by providing veterinarians with special access to innovative treatments approved in another country for animals with unmet medical needs. VMD Sciences handles regulatory complexities, export certificates, import permits, and customs inquiries, allowing veterinarians to administer treatments under controlled conditions even before full market approval. Targeted at licensed veterinarians, veterinary specialists, and pharmaceutical companies seeking early market entry.
• Drug Shortages Solutions Services addressing veterinary drug shortages by providing compliant pathways to import EU-approved alternatives and treatments licensed internationally, particularly for large animal veterinarians dealing with U.S. shortages. Combines deep industry knowledge with a mission-driven approach to ensure animals receive care despite supply limitations.
• Clinical Study Solutions End-to-end clinical study support services offering customized solutions to make veterinary practices research-ready, bridging the gap between cutting-edge advancements and everyday veterinary practice through in-clinic animal studies. Targeted at universities, community veterinarians, and pharmaceutical companies seeking groundbreaking research participation.
• Global Veterinary Export Pharmacy and Services A global export pharmacy located in Lake Worth, Florida, enabling veterinary practices, clinics, and distributors outside the United States to access FDA and USDA approved medications through fully compliant export channels. Includes access to medicines on Essential Medicines Lists from WSAVA, WVA, BROOKE, and WOAH, representing over 500,000 veterinarians in more than 180 countries.
• Importation Request Form / VMD Access A web-based platform and resource center for licensed veterinarians and pharmacists to request importation of treatments unavailable in their country, browse available treatments eligible for importation, and manage their treatment requests. Currently available for U.S. veterinarians and pharmacists with global access planned for a later date.

Quantifiable outcome

• >99% efficacy achieved against multi-drug-resistant parasites in sheep
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Covetrus: Covetrus is a global animal-health distribution and services company supplying pharmaceuticals, equipment, and software to veterinary practices. It is comparable to VMD Sciences as a broad incumbent in veterinary pharmaceutical distribution that could expand into managed access / cross-border importation as the category grows.
• Patterson Companies (Animal Health): Patterson Companies' Animal Health segment distributes veterinary pharmaceuticals, supplies, and equipment across North America. As an established veterinary distributor, it overlaps with VMD Sciences' core distribution-to-vet motion and represents a potential partner or competitor if it builds out MAP/importation services.
• Henry Schein Animal Health: Henry Schein Animal Health is a major distributor of veterinary products, services, and technology to practitioners. Comparable to VMD Sciences as a broad animal-health incumbent that could extend into managed access programs and cross-border importation.

Direct peers

• Clinigen Group: Clinigen is a global specialist pharmaceutical services company providing managed access / early access programs, clinical trial supply, and unlicensed medicine sourcing. Closest comparable peer to VMD Sciences because it operates the human-medicine equivalent of the VMAP model that VMD has adapted to veterinary care.
• Wedgewood Pharmacy: Wedgewood Pharmacy is one of the largest compounding pharmacies serving veterinary prescribers in the US, specializing in customized medications for animals. Comparable to VMD Sciences as a specialized veterinary pharmacy addressing unmet/unique prescribing needs through formulation rather than importation, with overlapping veterinarian customer base.
• Tanner Pharma Group: Tanner Pharma Group partners with manufacturers to provide managed access programs, international distribution, and comparator sourcing for unlicensed medicines. Comparable to VMD Sciences as a cross-border access and specialty distribution services company, validating the commercial model in human pharma.
• myTomorrows: myTomorrows provides early access and managed access programs for investigational and approved medicines, supporting physicians and patients globally. Comparable to VMD Sciences as a managed access program operator in human medicine, illustrating the proven service model VMD Sciences has translated to veterinary practice.
• Bova Veterinary: Bova Veterinary is an Australian veterinary compounding and specialty pharmaceutical supplier serving companion and production animal practices. It is comparable to VMD Sciences as a specialty veterinary pharma provider focused on access to treatments not commercially available in standard channels.
• IDIS (now part of Cencora): IDIS managed global early access and named-patient medicine supply programs across more than 100 countries. Comparable to VMD Sciences as one of the established human-medicine MAP operators that VMD Sciences' veterinary model mirrors in regulatory structure and cross-border distribution.

Emerging players

• Vetcove: Vetcove is a B2B veterinary supplies marketplace enabling practices to compare and order from multiple distributors. Comparable to VMD Sciences as a digital platform reshaping how veterinary practices source medications, though Vetcove focuses on procurement of standard products rather than cross-border importation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/vmdsciences
• LinkedInlinkedin.com/company/vmd-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VMD Sciences